Company Filing History:
Years Active: 2008-2020
Title: Discovering the Innovations of Garth E Ringheim
Introduction: Garth E Ringheim is a renowned inventor based in Belle Mead, New Jersey, known for his contributions to the field of biotechnology. With a robust portfolio of four patents, he has made significant advancements in the treatment of autoimmune diseases, particularly vitiligo and psoriasis.
Latest Patents: Garth Ringheim's latest patents showcase his innovative approaches to combating skin conditions. His patent titled "Methods of treating vitiligo using PD-1 binding antibodies" outlines techniques for managing, treating, or preventing vitiligo through proteins that interact with Programmed Death-1 (PD-1) to modulate its expression and activity. Furthermore, his other patent, "Methods of treating psoriasis using PD-1 binding antibodies," provides methodologies for managing autoimmune disorders by utilizing similar PD-1 binding proteins.
Career Highlights: Over the years, Garth has held prominent roles in major pharmaceutical companies, notably Aventis Pharmaceuticals Inc. and Celgene Corporation. His experience in these organizations has likely honed his skills in research and development, contributing to his successful patent endeavors.
Collaborations: Throughout his career, Garth has collaborated with notable professionals in the field, including Patrick Shum and Alexandre Gross. These partnerships have contributed to his innovative solutions and broadened his research perspective.
Conclusion: Garth E Ringheim’s work exemplifies the power of innovation in tackling pressing health issues. His patents not only reflect his expertise but also his commitment to advancing medical treatments for autoimmune diseases. As he continues to innovate, the impact of his work will undoubtedly resonate within the scientific community and beyond.